These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6653617)

  • 21. In vitro activity of norfloxacin in synthetic media and human urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.
    Shah PM; Ottnad-Walz M; Stille W
    Methods Find Exp Clin Pharmacol; 1983 Dec; 5(10):731-4. PubMed ID: 6231438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cinoxacin. A review of its pharmacological properties and therapeutic efficacy in the treatment of urinary tract infections.
    Sisca TS; Heel RC; Romankiewicz JA
    Drugs; 1983 Jun; 25(6):544-69. PubMed ID: 6347618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cinoxacin concentrations in plasma, urine and prostatic tissue after oral administration to man.
    Burt RA; Morgan T; Payne JP; Bonner RM
    Br J Urol; 1977 Apr; 49(2):147-52. PubMed ID: 858034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vitro comparative activity of norfloxacin in the comparison of pathogenic bacteria of the urinary tract].
    Carlone NA; Cuffini AM; Tullio V; Savoia D; Cavallo GP
    G Batteriol Virol Immunol; 1986; 79(1-6):85-97. PubMed ID: 3479370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Levels of pipemidic acid in biological fluids and human prostatic tissue. Experimental and clinical study].
    Gallego Gómez J; Jiménez Cruz F; Perales Juan JL; Rodríguez Ineva A; Orrico Sanz C; Collado Velez ML; Gobernado Serrano M
    Actas Urol Esp; 1984; 8(5):395-8. PubMed ID: 6524486
    [No Abstract]   [Full Text] [Related]  

  • 26. Interaction of quinolones with the theophylline metabolism in man: investigations with lomefloxacin and pipemidic acid.
    Staib AH; Harder S; Fuhr U; Wack C
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):289-3. PubMed ID: 2737798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Partition of cinoxacin and nalidixic acid in canine vascular and extravascular compartments.
    Szwed JJ; Redlich LR; Elliott RA; Kesler P; Black HR; Yu PL
    J Pharm Pharmacol; 1979 Aug; 31(8):567-8. PubMed ID: 40006
    [No Abstract]   [Full Text] [Related]  

  • 28. Cinoxacin: competitive inhibitory effect on p-aminohippurate transport and its uptake in renal cortical slices.
    Gemba M; Komamura T; Matsushima Y; Itoh T; Miyata K; Nakamura M
    Arch Int Pharmacodyn Ther; 1983 Feb; 261(2):308-15. PubMed ID: 6838288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rosoxacin and cinoxacin distribution in prostate, vagina, and female urethra. An experimental study in dogs.
    Maigaard S; Frimodt-Möller N; Hoyme U; Madsen PO
    Invest Urol; 1979 Sep; 17(2):149-52. PubMed ID: 468515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The influence of pipemidic acid on epinephrine and collagen induced platelet aggregation in vitro].
    Reuter HD; Thiele S
    Arzneimittelforschung; 1985; 35(8):1326-9. PubMed ID: 4074448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative in vitro studies with 4-quinolone antimicrobials.
    Felmingham D; O'Hare MD; Robbins MJ; Wall RA; Williams AH; Cremer AW; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(5):317-29. PubMed ID: 2941259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical studies on pipemidic acid.
    Ueda Y; Matsumoto F; Saito A; Ohkoshi M; Kawamura N; Nishiura T; Kawada Y; Ban Y
    Jpn J Antibiot; 1978 Sep; 31(9):528-35. PubMed ID: 101691
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapy of urinary tract infections. Clinical experience comparing norfloxacin to other quinolones].
    Fischetti G; Stillitani E; Michetti P; Massa P; Mastroberardino G
    Minerva Urol Nefrol; 1990; 42(4):211-3. PubMed ID: 2095636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cinoxacin (Cinobac, Eli Lilly & Co.).
    Guay DR
    Drug Intell Clin Pharm; 1982 Dec; 16(12):916-21. PubMed ID: 6759090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-blind comparison of cinoxacin and nitrofurantoin in the treatment of urinary tract infection.
    Schneider RE
    Clin Ther; 1982; 4(5):390-4. PubMed ID: 7039840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective decontamination of the digestive tract by pipemidic acid.
    Muytjens HL; van Veldhuizen GL; Welling GW; van der Ros-van de Repe J; Boerema HB; van der Waaij D
    Antimicrob Agents Chemother; 1983 Dec; 24(6):902-4. PubMed ID: 6419675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time-dependent elimination of cinoxacin in rats.
    Koike M; Norikura R; Mizojiri K; Sugeno K
    J Pharm Sci; 1984 Dec; 73(12):1697-700. PubMed ID: 6527237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cinoxacin: pharmacokinetics and the effect of probenecid.
    Israel KS; Black HR; Nelson RL; Brunson MK; Nash JF; Brier GL; Wolney JD
    J Clin Pharmacol; 1978 Oct; 18(10):491-9. PubMed ID: 711932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolites of pipemidic acid in human urine.
    Kurobe N; Nakamura S; Shimizu M
    Xenobiotica; 1980 Jan; 10(1):37-46. PubMed ID: 7385914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cinoxacin (Cinobac)--a new drug for urinary tract infections.
    Med Lett Drugs Ther; 1981 Jun; 23(13):57-8. PubMed ID: 7017366
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.